Fallbericht
Systemic bevacizumab therapy for recurrent laryngeal papillomatosis – a case report
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S153
DOI: 10.1055/s-0044-1784474 ↗Kurz gefasst
Fallbericht in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Veronika Kolb und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Systemic bevacizumab therapy for recurrent laryngeal papillomatosis – a case report
Zitieren
APA
Kolb, V., & Hornberger, C. (2024). Systemic bevacizumab therapy for recurrent laryngeal papillomatosis – a case report. Laryngo-Rhino-Otologie, 103(S 02 S 02), S153. https://doi.org/10.1055/s-0044-1784474
Vancouver
Kolb V, Hornberger C. Systemic bevacizumab therapy for recurrent laryngeal papillomatosis – a case report. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S153. doi:10.1055/s-0044-1784474
BibTeX
@article{Kolb2024,
author = {Kolb, Veronika and Hornberger, Cornelia},
title = {Systemic bevacizumab therapy for recurrent laryngeal papillomatosis – a case report},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S153},
doi = {10.1055/s-0044-1784474}
}
EUVIMED